Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.4.1627

Recurrence Season Impacts the Survival of Epithelial Ovarian Cancer Patients  

Liu, Xiao-Hui (Zhong-Shan-Men In-patient Department, Tianjin Medical University Cancer Institute and Hospital, National Clinical Center for Cancer, Key Laboratory of Cancer Prevention and Therapy)
Man, Ya-Nan (Zhong-Shan-Men In-patient Department, Tianjin Medical University Cancer Institute and Hospital, National Clinical Center for Cancer, Key Laboratory of Cancer Prevention and Therapy)
Wu, Xiong-Zhi (Zhong-Shan-Men In-patient Department, Tianjin Medical University Cancer Institute and Hospital, National Clinical Center for Cancer, Key Laboratory of Cancer Prevention and Therapy)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.4, 2014 , pp. 1627-1632 More about this Journal
Abstract
Background: Several studies indicated that the diagnosis season affects the prognosis of some cancers, such as examples in the prostate, colon and breast. This retrospective study aimed to investigate whether the diagnosis and recurrent season impacts the prognosis of epithelial ovarian cancer patients. Methods: From January 2005 to August 2010, 161 epithelial ovarian cancer patients were analyzed and followed up until August 2013. Kaplan-Meier survival curves and the log-rank test were used to make the survival analysis. Multivariate analysis was conducted to identify independent prognostic factors. Results: The prognostic factors of overall survival in epithelial ovarian cancer patients included age, clinical stage, pathological type, histological grade, residual disease after primary surgery, recurrent season and adjuvant chemotherapy cycles. Moreover, clinical stage, histological grade, residual disease after primary surgery, recurrent season and adjuvant chemotherapy cycles also impacted the progression-free survival of epithelial ovarian cancer patients. The diagnosis season did not have a significantly relationship with the survival of operable epithelial ovarian cancer patients. Median overall survival of patients with recurrent month from April to November was 47 months, which was longer (P < 0.001) than that of patients with recurrence month from December to March (19 months). Median progression-free survival of patients with recurrence month from April to November and December to March was 20 and 8 months, respectively (P < 0.001). Conclusion: The recurrence season impacts the survival of epithelial ovarian cancer patients. However, the diagnosed season does not appear to exert a significant influence.
Keywords
Season; vitamin D; operable epithelial ovarian cancer; recurrence; prognosis;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Tuohimaa P, Pukkala E, Scelo G, et al (2007). Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer, 43, 1701-12.   DOI   ScienceOn
2 Turna A, Pekcolaklar A, Metin M, Yaylim I, Gurses A (2012). The effect of season of operation on the survival of patients with resected non-small cell lung cancer. Interact Cardiovasc Thorac Surg, 14, 151-5.   DOI
3 Vik T, Try K, Stromme JH (1980). The vitamin D status of man at 70 degrees north. Scand J Clin Lab Invest, 40, 227-32.   DOI
4 Porojnicu AC, Robsahm TE, et al (2007). Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role? Lung Cancer, 55, 263-70.   DOI   ScienceOn
5 Porojnicu A, Robsahm TE, Berg JP, Moan J (2007). Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D. J Steroid Biochem Mol Biol, 103, 675-8.   DOI   ScienceOn
6 Porojnicu AC, Dahlback A, Moan J (2008). Sun exposure and cancer survival in Norway: changes in the risk of death with season of diagnosis and latitude. Adv Exp Med Biol, 624, 43-54.   DOI
7 Porojnicu AC, Lagunova Z, et al (2007). Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway. Breast Cancer Res Treat, 102, 323-8.   DOI   ScienceOn
8 Poskitt EM, Cole TJ, Lawson DE (1979). Diet, sunlight, and 25-hydroxy vitamin D in healthy children and adults. Br Med J, 1, 221-3.   DOI
9 Robsahm TE, Tretli S, Dahlback A, Moan J (2004). Vitamin D3 from sunlight may improve the prognosis of breast-, colonand prostate cancer (Norway). Cancer Causes Control, 15, 149-58.   DOI   ScienceOn
10 Roychoudhuri R, Robinson D, Coupland V, Holmberg L, Moller H (2009). Season of cancer diagnosis exerts distinct effects upon short- and long-term survival. Int J Cancer, 124, 2436-41.   DOI   ScienceOn
11 Salazar-Martinez E, Lazcano-Ponce EC, Gonzalez LG, Escudero-De LRP, Hernandez-Avila M (2002). Nutritional determinants of epithelial ovarian cancer risk: a case-control study in Mexico. Oncology, 63, 151-7.   DOI   ScienceOn
12 Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.   DOI   ScienceOn
13 Thigpen T, Brady MF, Omura GA, et al (1993). Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience. Cancer, 71, 606-14.
14 Mainio A, Hakko H, Koivukangas J, Niemela A, Rasanen P (2006). Winter birth in association with a risk of brain tumor among a Finnish patient population. Neuroepidemiology, 27, 57-60.   DOI   ScienceOn
15 Lefkowitz ES, Garland CF (1994). Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol, 23, 1133-6.   DOI   ScienceOn
16 Mizoue T (2004). Ecological study of solar radiation and cancer mortality in Japan. Health Phys, 87, 532-8.   DOI
17 Liigant A, Kulla A, Linnamagi U, Asser T, Kaasik AE (2001). Survival of patients with primary CNS tumours in Estonia. Eur J Cancer, 37, 1895-903.   DOI   ScienceOn
18 Lim HS, Roychoudhuri R, Peto J, et al (2006). Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer, 119, 1530-6.   DOI   ScienceOn
19 Mehta RG, Mehta RR (2002). Vitamin D and cancer. J Nutr Biochem, 13, 252-64.   DOI   ScienceOn
20 Moan J, Porojnicu AC, Robsahm TE, et al (2005). Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B, 78, 189-93.   DOI   ScienceOn
21 Mosekilde L, Nielsen LR, Larsen ER, Moosgaard B, Heickendorff L (2005). [Vitamin D deficiency. Definition and prevalence in Denmark]. Ugeskr Laeger, 167, 29-33.
22 Oguz A, Unal D, Kurtul N, et al (2013). Season of diagnosis and survival of advanced lung cancer cases - any correlation? Asian Pac J Cancer Prev, 14, 4325-8.   DOI   ScienceOn
23 Omura GA, Brady MF, Homesley HD, et al (1991). Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol, 9, 1138-50.   DOI
24 Heintz AP, Odicino F, Maisonneuve P, et al (2006). Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet, 95, S161-92.   DOI   ScienceOn
25 Grant WB (2003). Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res, 164, 371-7.   DOI
26 Hoskins WJ (1989). The influence of cytoreductive surgery on progression-free interval and survival in epithelial ovarian cancer. Baillieres Clin Obstet Gynaecol, 3, 59-71.   DOI   ScienceOn
27 Hakko H, Rasanen P, Niemela A, Koivukangas J, Mainio A (2009). Season of tumor surgery in relation to deaths among brain tumor patients: does sunlight and month of surgery play a role in brain tumor deaths? Acta Neurochir (Wien), 151, 1369-75.   DOI
28 Hanchette CL, Schwartz GG (1992). Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer, 70, 2861-9.   DOI
29 Hill C, Doyon F (2006). [The frequency of cancer in France in year 2002, and trends since 1968]. Bull Cancer, 93, 7-11.
30 Hoskins WJ, McGuire WP, Brady MF, et al (1994). The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol, 170, 974-9, 979-80.   DOI   ScienceOn
31 Kizildag S, Ates H, Kizildag S (2010). Treatment of K562 cells with 1,25-dihydroxyvitamin D3 induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCLXL, and p21. Ann Hematol, 89, 1-7.
32 Goodman MT, Wu AH, Tung KH, et al (2002). Association of dairy products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol, 156, 148-57.   DOI   ScienceOn
33 Freedman DM, Dosemeci M, McGlynn K (2002). Sunlight and mortality from breast, ovarian, colon, prostate, and non- melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med, 59, 257-62.   DOI   ScienceOn
34 Bidoli E, La Vecchia C, Talamini R, et al (2001). Micronutrients and ovarian cancer: a case-control study in Italy. Ann Oncol, 12, 1589-93.   DOI   ScienceOn
35 Bouillon R, Eelen G, Verlinden L, et al (2006). Vitamin D and cancer. J Steroid Biochem Mol Biol, 102, 156-62.   DOI   ScienceOn
36 Garland CF, Mohr SB, Gorham ED, Grant WB, Garland FC (2006). Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer. Am J Prev Med, 31, 512-4.   DOI   ScienceOn
37 Genkinger JM, Hunter DJ, Spiegelman D, et al (2006). Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev, 15, 364-72.   DOI   ScienceOn
38 Grant WB (2002). An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer, 94, 1867-75.   DOI   ScienceOn
39 Hoskins WJ, Bundy BN, Thigpen JT, Omura GA (1992). The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol, 47, 159-66.   DOI   ScienceOn
40 Mutlu H, Akca Z, Cihan YB, et al (2013). Is season a prognostic factor in breast cancer? Asian Pac J Cancer Prev, 14, 743-6.   DOI   ScienceOn